Oxurion Announces Extraordinary General Shareholders’ Meeting

Oxurion Announces Extraordinary General Shareholders’ Meeting

Leuven, BELGIUM – June 4, 2024 – 07:00 PM CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, announces an extraordinary general shareholders’ meeting to be held on Thursday July 4, 2024 at 11:00 AM (CET).

This extraordinary general shareholders’ meeting regards the proposal of share consolidation in respect of all outstanding shares of the Company by means of a 1-for-10,000 share consolidation.

The convening notice and other documents pertaining to the shareholders’ meeting, can be consulted on Oxurion’s website Oxurion/shareholders.

About Oxurion

Oxurion (Euronext Brussels: OXUR) is engaged in developing next-generation standard of care ophthalmic therapies for the treatment of retinal disease. Oxurion is based in Leuven, Belgium. More information is available at www.oxurion.com.

Please contact for additional information:

Attachment

• NL

You May Also Be Interested In

• Space Force Selects Rocket Lab For Space Data Network Consortium, Awarded $12M in Contracts to Support Global Military Communications Network
• AXIL Brands, Inc. Reports Fiscal 2026 and Fourth Quarter Financial Results
• OMNIQ Corp. Issues Second Quarter 2026 Shareholder Letter and Reports Financial Results